Ipsen
Board
3 directors, 1 auditor, last change in 2025Director
since 01-05-2023
term until 30-04-2029
listed in the 2025 annual accounts, filed on 17-07-2026
Director (not named in the articles)
since 01-06-2025
6-year term from 2025
listed in the 2025 annual accounts, filed on 17-07-2026
Director (not named in the articles)
since 01-09-2025
6-year term from 2025
listed in the 2025 annual accounts, filed on 17-07-2026
Statutory auditor, permanent representative Brecht Buysschaert
current term since 28-05-2024
term until 25-05-2027
listed in the 2025 annual accounts, filed on 17-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Two directors jointlydeed of 20-03-2024
Mandates through the years
17 names, the dashed line is todayJana Smidlova
Director
Director
CATHERINE ABI-HABIB
Director (not named in the articles)
Director (not named in the articles)
RAFAEL GIGLIO
Director (not named in the articles)
Director (not named in the articles)
KPMG Bedrijfsrevisoren BV
Statutory auditor
Statutory auditor
ABLA ABRIAL
Director
Director
AGATHE PALLIÈRE-CALINE
Director
Director
Vincent Stéphane Carrère
Director
Director
Michal Koutný
Director
Director
Jeroen Murk
Director
Director
Sophie Jacq
Director
Director
Visciglio Alexandre
Director
Director
Sandrine Gaillard
Director
Director
Mathieu Savarzeix
Director
Director
Sunjeet Sawhney
Director
Director
Jerome Viallard
Director
Director
Pascal Waucquez
Director
Director
Sunjeet Sawhriey
Director
Director
BoardEarlierRest of the termmandate already running before its first mentionend not dated
Mandates as a list
- Jana Smidlova
- Director, from 01-05-2023 to date
- CATHERINE ABI-HABIB
- Director (not named in the articles), from 01-06-2025 to date
- RAFAEL GIGLIO
- Director (not named in the articles), from 01-09-2025 to date
- KPMG Bedrijfsrevisoren BV
- Statutory auditor, from 30-04-2021 to date
- ABLA ABRIAL
- Director, appointed by deed of 03-11-2023, until 01-09-2025
- AGATHE PALLIÈRE-CALINE
- Director, from before 31-12-2022 to 01-06-2025
- Vincent Stéphane Carrère
- Director, appointed by deed of 25-11-2021, until 25-08-2023
- Michal Koutný
- Director, appointed by deed of 07-07-2022, until 23-06-2023
- Jeroen Murk
- Director, appointed by deed of 12-09-2022, until 13-03-2023
- Sophie Jacq
- Director, appointed by deed of 14-01-2021, until 12-09-2022
- Visciglio Alexandre
- Director, appointed by deed of 30-01-2020, until 07-07-2022
- Sandrine Gaillard
- Director, appointed by deed of 14-01-2021, until 01-11-2021
- Mathieu Savarzeix
- Director, from before 09-04-2019 to 30-11-2020
- Sunjeet Sawhney
- Director, appointed by deed of 30-01-2020, until 30-11-2020
- Jerome Viallard
- Director, until 09-04-2019
- Director, until 27-12-2019
- Pascal Waucquez
- Director, until 09-04-2019
- Director, until 27-12-2019
- Sunjeet Sawhriey
- Director, appointed by deed of 27-12-2019, no longer listed in the 2025 annual accounts
Control
Parent
Ipsen Pharma SAS FR
29,759 voting rights
89.85%
This company
Ipsen
Equity €119.9m
Profit €4.2m in 2025
Capital
- Capital
- €78,748,000
- Shares
- 33,120 in the 2025 annual accounts
- Contribution per share
- €2,378
- Equity per share
- €3,620 in 2025
- Source
- deed of 20-03-2024
Owners through the years
as the annual accounts name themOwners as a list
- Ipsen Pharma SAS
- Ipsen Pharma SA
- Ipsen SA
Source: shareholder structure in its own accounts, parent in its own accounts
Articles of association
deed of 20-03-2024 (in Dutch)- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 3 directors
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Fourth Tuesday of May at 15:00
Shareholders
3 ownersOwners 3
- Ipsen Pharma SASFRparentSourceown accounts 202589.85%
- Ipsen Pharma SAESSourceown accounts 202510.14%
- Ipsen SAFRSourceown accounts 20250.01%